Key Tech & BD - DDP 2016
-
Upload
andy-rogers -
Category
Documents
-
view
321 -
download
1
Transcript of Key Tech & BD - DDP 2016
BD, BD logo and all other trademarks are property of Becton, Dickinson and Company. © 2016 BD.1
3 Months from Concept to Demo:
Mobile Device Case Study
For internal use only
Innovation at BD – Focus on key market trends and customer unmet needs, leads to new product development
TREA
TMEN
T
CARE SETTINGS
Hospital Home
Acu
teC
hro
nic
Medication Adherence and
Smart technology
BD SafetyGlide™
Anti-Needle Stick and Shielding
BD Eclipse™BD Preventis™
BD UltraSafe™
BD Neopak XSi™
BD Neopak™
Introduction of large molecules (mABs)
Pro
ph
ylac
tic
BD Durashield™
Larger volumes/Higher Viscosities
BD HyFlow™BD Libertas™
Patient Comfort and alternate delivery
mechanisms
BD Uniject™
5 bevel needle
BD Soluvia™30G XTW
BD Accuspray™
BD Hypak™
Ready to Administer Chronic Therapies Move
to Self-Administration
BD Vystra™
BD UltraSafe Plus™
BD Physioject™
Alternate Care
Increasing Quality Standards
BD Hypak™ for Vaccines
BD SterifillAdvance™BD Hylok™
BD, BD logo and all other trademarks are property of Becton, Dickinson and Company. © 2016 BD.3
Drug Delivery PARTNERSHIP
• Tapping into potential opportunities resulting from trends and unmet needs
• Whether innovating in the area of programs, technologies, or business
models, partnerships can be an important path to enable success
• Adapting principles from the lean start-up approach to increase speed, and
lower risk, in innovation
BD, BD logo and all other trademarks are property of Becton, Dickinson and Company. © 2016 BD.4
BD has collaborated to develop new technology . . .
PDA Universe of Pre-filled Syringes and Injection Devices, Las Vegas, NV. October 2012
BD, BD logo and all other trademarks are property of Becton, Dickinson and Company. © 2016 BD.5
BD has collaborated to pilot new ideas and define solutions . . .
Pharmacy Times March 23, 2015
BD, BD logo and all other trademarks are property of Becton, Dickinson and Company. © 2016 BD.6
BD has collaborated with external organizations to help educate and drive change . . .
BD Sponsored AAP’s Vaccine Storage &
Handling Best Practices Exhibit at their
2015 Annual Conference
American Academy of Pediatrics
BD, BD logo and all other trademarks are property of Becton, Dickinson and Company. © 2016 BD.7
How do we innovate for the evolving ecosystem and leverage best
practices from other industries to develop solutions?
1. Business-
hypothesis-
driven
experimentation
2. Rapid and
iterative product
releases
3. “Validated
Learning"
How do we decrease cycle times for fast
moving markets where solutions require
unique and novel technologies and/or
business models?
Market
Trends
Unmet
Needs
Hypotehsize
Soluions
BD, BD logo and all other trademarks are property of Becton, Dickinson and Company. © 2016 BD.8
Mobile Immunization Case Study: Market Trends & Unmet Needs
Questions / Unmet Needs
Across the 5 P’s
• Public Health – How can vaccine coverage/uptake be improved?
• Providers
– Can device technology help enable new business models to deliver
care differently?
– Cold chain constraints
– Cold chain integrity
• Pharma – balancing needs of stakeholders; finding a
differentiation vector
• Payers – It’s all about the outcomes
• Patients – Quality affordable convenient healthcare
Market/Customer Trends
• Retailization of Immunization . . .and care in general
• Care moving closer to the patient
• Healthcare “when I want it, where I want it”
• Consumers & technology
• Decentralized healthcare
Immunization’s Role in the Emerging
Retail Care Space
• Vaccination - many times the first client engagement
– the most common retail clinic services billed - flu shot, vaccine
administration and strep test*
* http://www.athenahealth.com/blog/2013/10/30/where-do-retail-health-clinics-fit-into-the-market
Market
TrendsUnmet
Needs
BD, BD logo and all other trademarks are property of Becton, Dickinson and Company. © 2016 BD.9
A Look Ahead (or Back to the Future)
Care Evolution
The House
Call
The Trip to the
Dr.
The Trip to the Store
Care Comes to You
Virtual Mobile
BD, BD logo and all other trademarks are property of Becton, Dickinson and Company. © 2016 BD.10
Mobile Immunization Case Study:
Trends & Unmet Needs Lead to New Opportunities . . .
Presentation by Jane Huston , National Adult and Influenza Immunization Summit, Atlanta, GA May 14, 2015
BD, BD logo and all other trademarks are property of Becton, Dickinson and Company. © 2016 BD.11
Case Study: From unmet needs and market trends, features and benefits were
identified for our hypothesized solution and provided to our technical partner
Feature Benefit
Smart, Universal Injector • 100% data reporting to cloud
• Automatic link to EMR
• Data available for patient tracking, outcomes
determinations
• Predictive vaccine production
BD Hypak™ Tub • Minimal changes to fill/finish for pharma
High density packaging • Minimize cold storage space requirements
Lock & technology (syringe to injector) • Limit medication errors (5 rights)
Prefilled syringes • Ready, easy to use format for HCP
External Partners;To bring this to life quickly,
we partnered with KeyTech –
who had a team they could
dedicate to this project, the
next day!
BD – Franklin Lakes, NJ BD – Pont de Claix, FranceBD – Research Triangle Park, NC
Hypothesize
Soluions
BD, BD logo and all other trademarks are property of Becton, Dickinson and Company. © 2016 BD.2
Note: This product could be subject to regulatory approval
Mobile Drug Delivery Concept
BD, BD logo and all other trademarks are property of Becton, Dickinson and Company. © 2016 BD.3
Traditional vs. Lean
Planning & Feasibility
Alpha
Beta
V&V
Ramp-up
Develop Prototype
Traditional
Lean Prototyping
6-12 months to
functional prototype
3 months to
functional prototype
*Prototype development timeline determined on a case-by-case basis and may be longer than three months.
BD, BD logo and all other trademarks are property of Becton, Dickinson and Company. © 2016 BD.4
Lean Prototyping Process
Define User Inputs
Be a Maker
Evaluate Form
Prove Functionality
Integrate
BD, BD logo and all other trademarks are property of Becton, Dickinson and Company. © 2016 BD.5
Define User Inputs
Clinical Knowledge
Experience
Business Perspective
Dreamer
BD, BD logo and all other trademarks are property of Becton, Dickinson and Company. © 2016 BD.6
Be a Maker
BD, BD logo and all other trademarks are property of Becton, Dickinson and Company. © 2016 BD.7
Evaluate Form
BD, BD logo and all other trademarks are property of Becton, Dickinson and Company. © 2016 BD.8
Prove Functionality
BD, BD logo and all other trademarks are property of Becton, Dickinson and Company. © 2016 BD.9
Integrate
BD, BD logo and all other trademarks are property of Becton, Dickinson and Company. © 2016 BD.10
Functional Prototype
BD, BD logo and all other trademarks are property of Becton, Dickinson and Company. © 2016 BD.11
Functional Prototype
Load Syringe
BD, BD logo and all other trademarks are property of Becton, Dickinson and Company. © 2016 BD.12
Present to Patient
BD, BD logo and all other trademarks are property of Becton, Dickinson and Company. © 2016 BD.13
Attach Needle
BD, BD logo and all other trademarks are property of Becton, Dickinson and Company. © 2016 BD.14
Administer
BD, BD logo and all other trademarks are property of Becton, Dickinson and Company. © 2016 BD.15
Eject Syringe
BD, BD logo and all other trademarks are property of Becton, Dickinson and Company. © 2016 BD.17
Traditional vs. Lean
Planning & Feasibility
Alpha
Beta
V&V
Ramp-up
Develop Prototype
Traditional
Lean Prototyping
6-12 months to
functional prototype
3 months to
functional prototype
BD, BD logo and all other trademarks are property of Becton, Dickinson and Company. © 2016 BD.12
Final Thoughts . . .
Lean Principles: At Work in the Front-End and Back-End of Innovation
Key process inputs:
Broad and deep market sensing
Understand unmet needs across multiple enterprise stakeholders
Critical to assess the potential for disruptive healthcare delivery technology and/or
business models
Lean innovation principles:
Co-innovation
Early engagement with key stakeholders and partners
Identify super-users (unicorns)
Develop the minimum viable prototype
Critical to accelerate innovation and reduce risk